πŸ‡ΊπŸ‡Έ FDA
Patent

US 10273225

Pyrazines as modulators of GPR6

granted A61KA61K31/497A61K31/506

Quick answer

US patent 10273225 (Pyrazines as modulators of GPR6) held by Takeda Pharmaceutical Company Limited expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/497, A61K31/506, A61K31/551, A61P